MV TELEGRAPH DAILY NEWS
The Trump administration on Thursday imposed new tariffs on brand-name drugs from drug companies that have not reached agreements with the president to lower their U.S. drug prices – a long-awaited move that is likely to affect only a small fraction of drugmakers. “We need to ensure that our drug supply is protected, safe and …
Continue reading “Trump is getting ready drug tariffs of as much as 100%”
A drone view shows the Eli Lilly logo on the company’s office in San Diego, California, November 21, 2025. Mike Blake | Reuters BEIJING – US pharmaceutical giant Eli Lilly has struck a $2.75 billion deal to bring drugs developed using artificial intelligence by Hong Kong-based Insilico Medicine to the global market. According to the …
Continue reading “Eli Lilly reaches deal to carry AI-developed medication to international market”
Thomas Fuller | Photo only | Getty Images Pfizer On Monday, the company said it would seek regulatory approval for a Lyme disease vaccine candidate, even though the shot failed in a late-stage trial. Pfizer said the vaccine missed the study’s statistical target because not enough people in the study had Lyme disease to rely …
Continue reading “Pfizer’s Lyme illness vaccine fails trial, firm applies for FDA approval”
A mini burger, mini fries and mini beer, Clinton Hall’s “Teeny Weeny Mini Meal”, is pictured next to a regular-sized combo on Dec. 8, 2025 in New York City. Approximately one in eight American adults are currently taking drugs from the class of GLP-1 agonists that are now popular for weight loss, according to a …
Continue reading “Eating places add protein, fiber for weight reduction drug customers”
Shares of Eli Lilly fell 6% on Tuesday and are on track for their worst day since February after a downgrade by HSBC. The gist of HSBC’s claim: Wall Street is overly optimistic about the size of the GLP-1 obesity market. The company’s analysts expect it to be between $80 billion and $120 billion in …
Continue reading “Eli Lilly shares slide after bearish analyst name – this is our take”
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston. Brian Snyder | Reuters Vertex Pharmaceuticals said its experimental drug for a rare kidney disease successfully passed a Phase 3 trial, a key step in the company’s journey to diversify beyond its main cystic fibrosis drugs. The Boston-based drugmaker said Monday …
Continue reading “The Vertex kidney drug povetacicept is profitable within the examine for IgAN”
A few years ago, Grace Guo began to long for places in New York City where hanging out with friends didn’t necessarily have to involve alcohol. Guo was newly sober and surrounded by friends who also didn’t want to drink. She said she wanted alternatives to the typical social scene. After some research, she landed …
Continue reading “Within the booming enterprise of wellness golf equipment and third areas”
Jim Cramer explained Tuesday morning why the Investing Club is trying to strike a delicate balance with its actions during the Iran War’s impact on the stock market. “Those who flee in moments like these can never get back in,” Jim stressed during the morning session, as Wall Street sold off sharply on Monday following …
Metformin has been used for decades. Not as a wellness trend. Not as a supplement experiment. As a prescription drug with a long safety record in metabolic disease. What has changed is how researchers now view the drug. Instead of asking only how Metformin lowers blood glucose, the question has widened. Can Metformin support longevity? …
Continue reading “Metformin for Longevity: Understanding Its Anti-Aging Potential”
The logo of pharmaceutical company Novo Nordisk is seen outside its offices in Bagsvaerd on the outskirts of Copenhagen on November 24, 2025. Tom Little | Reuters Novo Nordisk will begin rolling out the first-ever GLP-1 weight loss pill in the United States on Monday, the company announced, marking a new chapter in obesity treatment …
Continue reading “First GLP-1 anti-obesity capsule from Novo Nordisk launches within the US”
